Product nameAnti-PGGT1B antibody
DescriptionRabbit polyclonal to PGGT1B
Tested applicationsSuitable for: IHC-P, WBmore details
Species reactivityReacts with: Mouse, Rat, Human
antigen sequence, corresponding to amino acids 213-347 of Human PGGT1B.
- Human breast tissue; RT 4, U 251 MG, Human liver and tonsil lysates.
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferpH: 7.20
Preservative: 0.02% Sodium azide
Constituents: 59% PBS, 40% Glycerol
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab122122 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/50 - 1/200. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.|
|WB||1/250 - 1/500.|
FunctionCatalyzes the transfer of a geranyl-geranyl moiety from geranyl-geranyl pyrophosphate to a cysteine at the fourth position from the C-terminus of proteins having the C-terminal sequence Cys-aliphatic-aliphatic-X. Acts on the Rac1, Rac2, Rap1A and Rap1B proteins. The beta subunit is responsible for peptide-binding.
Sequence similaritiesBelongs to the protein prenyltransferase subunit beta family.
Contains 4 PFTB repeats.
- Information by UniProt
- BGGI antibody
- Geranylgeranyl transferase type I subunit beta antibody
- Geranylgeranyl transferase type-1 subunit beta antibody
Lane 1: NIH-3T3 cell lysate (Mouse embryonic fibroblast cells)
Lane 2: NBT-II cell lysate (Rat Wistar bladder tumour cells)
All lanes : Anti-PGGT1B antibody (ab122122) at 1/250 dilution
Lane 1 : RT 4 lysate
Lane 2 : U 251 MG lysate
Lane 3 : Human plasma lysate
Lane 4 : Human liver lysate
Lane 5 : Human tonsil lysate
Developed using the ECL technique
ab122122, at a 1/75 dilution, staining PGGT1B in paraffin-embedded Human breast tissue by Immunohistochemistry.
ab122122 has not yet been referenced specifically in any publications.